Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Not Applicable
Active, not recruiting
- Conditions
- Smoking CessationTobacco
- Interventions
- Device: smartphone applications
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT05038852
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Phase 1
Recruiting
- Conditions
- Metastatic Malignant Neoplasm in the LiverAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LungMetastatic Malignant Solid Neoplasm
- Interventions
- Other: Hafnium Oxide-containing Nanoparticles NBTXR3Radiation: Radiation Therapy
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05039632
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work
Withdrawn
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
- Interventions
- Other: Survey Administration
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05038384
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
Phase 2
Recruiting
- Conditions
- Metastatic CancerEndometrium CancerEndometrial Carcinoma
- Interventions
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05036681
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Phase 1
Not yet recruiting
- Conditions
- Gastric Adenocarcinoma
- Interventions
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05038098
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion
Not Applicable
Completed
- Conditions
- Breast CarcinomaInvasive Breast Carcinoma
- Interventions
- Procedure: Contrast-Enhanced MammographyProcedure: Digital Tomosynthesis MammographyOther: Electronic Health Record ReviewDrug: Iodinated Contrast Agent
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 89
- Registration Number
- NCT05036083
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
Not Applicable
Withdrawn
- Conditions
- Prostate NoduleProstate Cancer
- Interventions
- Radiation: 18F-fluciclovine
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05035732
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
Not Applicable
Recruiting
- Conditions
- Colorectal CancerColon Cancer
- Interventions
- Drug: AspirinDrug: Vitamin DDietary Supplement: DietOther: Physical ActivityBehavioral: Behavioral Support Counseling Sessions
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT05036109
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Patient Considerations of Social Media Account Management After Death
Active, not recruiting
- Conditions
- Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 117
- Registration Number
- NCT05035667
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
ProvoxLife Adoption Trends for Heat-Moisture Exchanger
Active, not recruiting
- Conditions
- Malignant Head and Neck Neoplasm
- Interventions
- Other: Clinical EvaluationProcedure: Physical ExaminationOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 130
- Registration Number
- NCT05036330
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath